SCHEMBL4540682

SCHEMBL4540682

O=Cc1cccn(Cc2ccc(F)c(F)c2)c1=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 11/20 0.45
▸ MAPT P10636 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ EGLN1 Q9GZT9 2/20 0.42
▸ VEGFA P15692 1/20 0.42
▸ HDAC3 O15379 2/20 0.42
▸ HDAC4 P56524 2/20 0.42
▸ HDAC1 Q13547 2/20 0.42
▸ HDAC7 Q8WUI4 2/20 0.42
▸ HDAC2 Q92769 2/20 0.42
▸ HDAC10 Q969S8 2/20 0.42
▸ HDAC11 Q96DB2 2/20 0.42
▸ HDAC8 Q9BY41 2/20 0.42
▸ HDAC6 Q9UBN7 2/20 0.42
▸ HDAC9 Q9UKV0 2/20 0.42
▸ HDAC5 Q9UQL6 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13332848 0.82 SMN1; SMN2 (0.44) MAPTLMNATP53THRBHDAC3
SCHEMBL13020328 0.79 HDAC3 (0.71) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL19723217 0.79 BRD4 (0.54) MAPTLMNAEGLN1VEGFAHDAC3
SCHEMBL13020361 0.78 HDAC3 (0.64) MAPTTP53THRBEGLN1VEGFA
SCHEMBL4540676 0.77 MAPT (0.44) PDPK1MAPTLMNATP53THRB
SCHEMBL8685733 0.77 ALDH1A1 (0.53) MAPTLMNASMN1; SMN2
SCHEMBL2621619 0.76 SMN1; SMN2 (0.53) PDPK1MAPTLMNATP53SMN1; SMN2
SCHEMBL14307762 0.75 PDPK1 (0.49) PDPK1MAPTLMNATP53SMN1; SMN2
SCHEMBL13306807 0.75 PDPK1 (0.54) PDPK1MAPTLMNASMN1; SMN2
SCHEMBL3348497 0.75 SMN1; SMN2 (0.52) PDPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017211946-A1 2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE COMPOUNDS AND THEIR USE AS DUAL INHIBITORS OF PDK1/AURA INTERNATIONAL SOCIETY FOR DRUG DEVELOPMENT S.R.L. (IT) 2017-12-14 — — WO disclosed
EP-2038272-B1 PYRIDINONYL PDK1 INHIBITORS SUNESIS PHARMACEUTICALS INC (US) 2013-09-04 — — EP disclosed
EP-2038272-A2 PYRIDINONYL PDK1 INHIBITORS Sunesis Pharmaceuticals, Inc. (US) 2009-03-25 — — EP disclosed
WO-2008005457-A2 PYRIDINONYL PDK1 INHIBITORS SUNESIS PHARMACEUTICALS (US) 2008-01-10 — — WO disclosed
Send feedback